PPAR-alpha dependent regulation of vanin-1 mediates hepatic lipid metabolism

Journal of Hepatology

Volumn 61, Issue 2, 2014, Pages 366-372

  Van Diepen, Janna A ^a   Jansen, Patrick A ^b   Ballak, Dov B ^a   Hijmans, Anneke ^a   Hooiveld, Guido J ^c   Rommelaere, Samuel ^d,e   Galland, Franck ^d,e   Naquet, Philippe ^d,e   Rutjes, Floris P J T ^f   Mensink, Ronald P ^g   Schrauwen, Patrick ^g   Tack, Cees J ^a   Netea, Mihai G ^a   Kersten, Sander ^c   Schalkwijk, Joost ^b   Stienstra, Rinke ^a,c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^e INSERM   (France)

^f RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^g MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Fasting; Fenofibrate; Lipid; Pantetheinase; Peroxisome proliferator activated receptor alpha ; PPAR; Steatosis; Triglyceride; Vanin

Indexed keywords

FENOFIBRATE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VANIN 1; AMIDASE; PANTETHEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ENZYME ACTIVITY; ENZYME INHIBITION; FATTY LIVER; FEMALE; GENE CONTROL; GENE FUNCTION; HUMAN; HUMAN TISSUE; INFLAMMATION; LIPID LIVER LEVEL; LIPID METABOLISM; LIVER CELL; LIVER METABOLISM; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; STARVATION; TISSUE MICROARRAY; ANIMAL; C57BL MOUSE; LIVER; METABOLISM; PHYSIOLOGY; WISTAR RAT;

AMIDOHYDROLASES; ANIMALS; FATTY LIVER; GPI-LINKED PROTEINS; HUMANS; LIPID METABOLISM; LIVER; MALE; MICE; MICE, INBRED C57BL; PPAR ALPHA; RATS; RATS, WISTAR; STARVATION;

EID: 84904747080     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.04.013     Document Type: Article

References (36)

1. S.A. Kliewer, S.S. Sundseth, S.A. Jones, P.J. Brown, G.B. Wisely, and C.S. Koble et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma Proc Natl Acad Sci U S A 94 1997 4318 4323
2. S. Kersten, J. Seydoux, J.M. Peters, F.J. Gonzalez, B. Desvergne, and W. Wahli Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting J Clin Invest 103 1999 1489 1498
3. M. Rakhshandehroo, B. Knoch, M. Muller, and S. Kersten Peroxisome proliferator-activated receptor alpha target genes PPAR Res 2010 2010 20 pages Article ID 612089. http://dx.doi.org/10.1155/2010/612089
4. S. Kersten, S. Mandard, P. Escher, F.J. Gonzalez, S. Tafuri, and B. Desvergne et al. The peroxisome proliferator-activated receptor alpha regulates amino acid metabolism FASEB J 15 2001 1971 1978
5. M. Guerre-Millo, C. Rouault, P. Poulain, J. Andre, V. Poitout, and J.M. Peters et al. PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance Diabetes 50 2001 2809 2814
6. T.G. Li, and J.Y.L. Chiang Regulation of bile acid and cholesterol metabolism by PPARs PPAR Res 2009 2009 15 pages Article ID 501739. http://dx.doi.org/10.1155/2009/501739
7. S. Rommelaere, V. Millet, T. Gensollen, C. Bourges, J. Eeckhoute, and N. Hennuyer et al. PPARalpha regulates the production of serum Vanin-1 by liver FEBS Lett 587 2013 3742 3748
8. K. Yamazaki, J. Kuromitsu, and I. Tanaka Microarray analysis of gene expression changes in mouse liver induced by peroxisome proliferator activated receptor alpha agonists Biochem Biophys Res Commun 290 2002 1114 1122
9. J.S. Moffit, P.H. Koza-Taylor, R.D. Holland, M.S. Thibodeau, R.D. Beger, and M.P. Lawton et al. Differential gene expression in mouse liver associated with the hepatoprotective effect of clofibrate Toxicol Appl Pharmacol 222 2007 169 179
10. P.A.M. Jansen, M. Kamsteeg, D. Rodijk-Olthuis, I.M.J.J. van Vlijmen-Willems, G.J. de Jongh, and M. Bergers et al. Expression of the vanin gene family in normal and inflamed human skin: induction by proinflammatory cytokines J Invest Dermatol 129 2009 2167 2174
11. G. Pitari, F. Malergue, F. Martin, J.M. Philippe, M.T. Massucci, and C. Chabret et al. Pantetheinase activity of membrane-bound Vanin-1: lack of free cysteamine in tissues of Vanin-1 deficient mice FEBS Lett 483 2000 149 154
12. F. Martin, F. Malergue, G. Pitari, J.M. Philippe, S. Philips, and C. Chabret et al. Vanin genes are clustered (human 6q22-24 and mouse 10A2B1) and encode isoforms of pantetheinase ectoenzymes Immunogenetics 53 2001 296 306
13. C. Berruyer, L. Pouyet, V. Millet, F.M. Martin, A. LeGoffic, and A. Canonici et al. Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity J Exp Med 203 2006 2817 2827
14. F. Sendo, and Y. Araki Regulation of leukocyte adherence and migration by glycosylphosphatidyl-inositol-anchored proteins J Leukoc Biol 66 1999 369 374
15. B.J. Kaskow, J.M. Proffitt, J. Blangero, E.K. Moses, and L.J. Abraham Diverse biological activities of the vascular non-inflammatory molecules - The Vanin pantetheinases (vol 417, pg 653, 2012) Biochem Biophys Res Commun 422 2012 786-786
16. M. Daugherty, B. Polanuyer, M. Farrell, M. Scholle, A. Lykidis, and V. de Crecy-Lagard et al. Complete reconstitution of the human coenzyme A biosynthetic pathway via comparative genomics J Biol Chem 277 2002 21431 21439
17. M. Rakhshandehroo, L.M. Sanderson, M. Matilainen, R. Stienstra, C. Carlberg, and P.J. de Groot et al. Comprehensive analysis of palpha-dependent regulation of hepatic lipid metabolism by expression profiling PPAR Res 2007 2007 13 pages Article ID 26839. http://dx.doi.org/10.1155/2007/26839
18. P.A.M. Jansen, J.A. van Diepen, B. Ritzen, P.L.J.M. Zeeuwen, I. Cacciatore, and C. Cornacchia et al. Discovery of small molecule vanin inhibitors: new tools to study metabolism and disease ACS Chem Biol 8 2013 530 534
19. J. Hoeks, N.A. van Herpen, M. Mensink, E. Moonen-Kornips, D. van Beurden, and M.K.C. Hesselink et al. Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance Diabetes 59 2010 2117 2125
20. M.C.E. Bragt, and R.P. Mensink Comparison of the effects of n-3 long chain polyunsaturated fatty acids and fenofibrate on markers of inflammation and vascular function, and on the serum lipoprotein profile in overweight and obese subjects Nutr Metab Cardiovasc Dis 22 2012 966 973
21. M.M. Haluzik, K. Anderlova, R. Dolezalova, A. Adamikova, D. Haluzikova, and J. Housova et al. Serum adipocyte fatty acid binding protein levels in patients with type 2 diabetes mellitus and obesity: the influence of fenofibrate treatment Physiol Res 58 2009 93 99
22. F. Kuipers, M.C. Jong, Y. Lin, M. Eck, R. Havinga, and V. Bloks et al. Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E-deficient mouse hepatocytes J Clin Invest 100 1997 2915 2922
23. B.H. Ruan, D.C. Cole, P. Wu, A. Quazi, K. Page, and J.F. Wright et al. A fluorescent assay suitable for inhibitor screening and vanin tissue quantification Anal Biochem 399 2010 284 292
24. D. Povero, A. Eguchi, C. Johnson, A. Wree, M. Lazic, and M. Parola et al. Hepatocyte-derived microparticles with a specific antigenic composition are released in blood during Nash development: implications for biomarkers development J Hepatol 58 2013 S34-S34
25. K. Kerkel, A. Spadola, E. Yuan, J. Kosek, L. Jiang, and E. Hod et al. Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation Nat Genet 40 2008 904 908
26. M.S. Kostapanos, A. Kei, and M.S. Elisaf Current role of fenofibrate in the prevention and management of non-alcoholic fatty liver disease World J Hepatol 5 2013 470 478
27. I. Garcia-Ruiz, C. Rodriguez-Juan, T. Diaz-Sanjuan, M.A. Martinez, T. Munoz-Yague, and J.A. Solis-Herruzo Effects of rosiglitazone on the liver histology and mitochondrial function in ob/ob mice Hepatology 46 2007 414 423
28. D. Patsouris, J.K. Reddy, M. Muller, and S. Kersten Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression Endocrinology 147 2006 1508 1516
29. M. Kahle, M. Horsch, B. Fridrich, A. Seelig, J. Schultheiss, and J. Leonhardt et al. Phenotypic comparison of common mouse strains developing high-fat diet-induced hepatosteatosis Mol Metab 2 2013 435 446
30. W. Motomura, T. Yoshizaki, N. Takahashi, S. Kumei, Y. Mizukami, and S.J. Jang et al. Analysis of vanin-1 upregulation and lipid accumulation in hepatocytes in response to a high-fat diet and free fatty acids J Clin Biochem Nutr 51 2012 163 169
31. M. Besouw, R. Masereeuw, L. van den Heuvel, and E. Levtchenko Cysteamine: an old drug with new potential Drug Discov Today 18 2013 785 792
32. C. Bocos, and E. Herrera Pantethine stimulates lipolysis in adipose tissue and inhibits cholesterol and fatty acid synthesis in liver and intestinal mucosa in the normolipidemic rat Environ Toxicol Pharmacol 6 1998 59 66
33. C.T. Wittwer, C.P. Graves, M.A. Peterson, E. Jorgensen, D.E. Wilson, and J.G. Thoene et al. Pantethine lipomodulation - evidence for cysteamine mediation in vitro and in vivo Atherosclerosis 68 1987 41 49
34. C. Berruyer, F.M. Martin, R. Castellano, A. Macone, F. Malergue, and S. Garrido-Urbani et al. Vanin-1(-/-) mice exhibit a glutathione-mediated tissue resistance to oxidative stress Mol Cell Biol 24 2004 7214 7224
35. L. Di Leandro, B. Maras, M.E. Schinina, S. Dupre, I. Koutris, and F.M. Martin et al. Cystamine restores GSTA3 levels in Vanin-1 null mice Free Radic Biol Med 44 2008 1088 1096
36. S. Meghari, C. Berruyer, H. Lepidi, F. Galland, P. Naquet, and J.L. Mege Vanin-1 controls granuloma formation and macrophage polarization in Coxiella burnetii infection Eur J Immunol 37 2007 24 32